Skip to main content
Top

Drugs & Aging

Issue 15/2003

Content (10 Articles)

Current Opinion

The Doctor’s Duty to the Elderly Patient in Clinical Trials

Antony Bayer, Mark Fish

Therapy In Practice

Long-Acting Injectable Antipsychotics in the Elderly

Prakash S. Masand, Sanjay Gupta

Adis Drug Profile

Donepezil

David R. Goldsmith, Lesley J. Scott

Adis Drug Profile

Donepezil in Vascular Dementia

David S. Geldmacher

Adis Drug Profile

Donepezil in Vascular Dementia

Gustavo C. Román

Adis Drug Profile

Donepezil in Vascular Dementia

Sandra E. Black

Correspondence

Galantamine vs Donepezil in the Treatment of Alzheimer’s Disease

Barry Goldlist, Michael Gordon, Gary Naglie

Correspondence

The Authors Reply

Gordon Wilcock, Ian Howe, Hilary Coles, Sean Lilienfeld, Luc Truyen, Young Zhu, Roger Bullock

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine